The Novartis Group is one of the biggest global pharmaceutical and healthcare groups. Novartis AG, with headquarters in Switzerland, was created in 1996 through a merger of Ciba-Geigy and Sandoz and is the holding company of the Novartis Group. The Group provides solutions addressing the evolving needs of patients worldwide by developing and delivering innovative medical treatments and drugs. In 2025, Novartis achieved net sales of USD 54.5 billion, total net income of USD 14 billion, and employed 75,267 full-time equivalent employees as of 31 December 2025. The Group also offers a wide range of career and training opportunities and maintains a substantial online presence.<\/p>\n
The disputed domain names information is the following:<\/p>\n
At the time of the filing of the Complaint, the disputed domain names did not resolve to an active website and have been passively held.<\/p>", "other_legal_proceedings": "
The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain names.<\/p>", "no_response_filed": "
The Complainant contends that the requirements of the Policy have been met and that the disputed domain names should be transferred to it.<\/p>\n
No administratively compliant Response has been filed. <\/span><\/p>\n It ought to be indicated that the Centre sent of the complaint but nor the advice of delivery thereof was returned to the Czech Arbitration Court. The notice of the Commencement of the administrative proceeding was therefore only sent by e-mail. Yet, the e-mail notice sent to postmaster@novartiiscareer.online<\/a> and to postmaster@novartiiscareer.com<\/a> were returned back undelivered as the e-mail addresses had permanent fatal errors. The e-mail notices were also sent to ubandawakibawa@gmail.com<\/a>, but the Czech Arbitration Court never received any proof of delivery or notification of undelivery. No further e-mail addresses could be found on the disputed sites.<\/p>\n The Respondent never accessed the online platform.<\/span><\/p>",
"rights": " The Complainant has, to the satisfaction of the Panel, shown the disputed domain names are identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
"no_rights_or_legitimate_interests": " The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain names (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
"bad_faith": " The Complainant has, to the satisfaction of the Panel, shown the disputed domain names have been registered and are being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
"procedural_factors": " The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
"decision": "Accepted",
"panelists": [
"David-Irving Tayer"
],
"date_of_panel_decision": "2026-11-02 00:00:00",
"informal_english_translation": " The Complainant is the owner of several trademarks including the word NOVARTIS, such as:<\/p>\n The Complainant is also the owner of numerous domain names comprising the mark NOVARTIS, including <novartis.com>, <novartis.ch>, and <novartispharma.com>.<\/p>",
"decision_domains": {
"novartiiscareer.online": "TRANSFERRED",
"novartiiscareer.com": "TRANSFERRED"
},
"panelist": null,
"panellists_text": null
}\n